These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 2296325)
1. [Treatment of AIDS patients with zidovudine]. Buijs L; Pietersz RN; van den Berg-Wolf MG; Reesink HW; ten Veen JH Ned Tijdschr Geneeskd; 1990 Jan; 134(2):71-5. PubMed ID: 2296325 [TBL] [Abstract][Full Text] [Related]
2. [Clinical experience with zidovudine in patients with acquired immunodeficiency syndrome. Analysis of 117 cases. Grupo Andaluz para el Estudio de las Enfermedades Infecciosas]. Biedma D; Bascuñana A; Viciana P; Causse M; Torres Tortosa M; Lozano de León F; Pujol E; Pachón J Rev Clin Esp; 1992 Sep; 191(4):187-92. PubMed ID: 1439038 [TBL] [Abstract][Full Text] [Related]
3. Zidovudine therapy, CD4+ and CD8+ counts are associated with a longer survival following AIDS onset. Fiala M; Swartz J; Teklehaimanot S; Kermani V; Funnye AS; Sayre JW; Gornbein JA Lymphology; 1997 Sep; 30(3):128-36. PubMed ID: 9313205 [TBL] [Abstract][Full Text] [Related]
4. Survival of patients receiving zidovudine before or after AIDS diagnosis: results of a German multicenter study. German AIDS Study Group. Clin Investig; 1994 Jan; 72(2):111-6. PubMed ID: 8186655 [TBL] [Abstract][Full Text] [Related]
5. [Zidovudine therapy in 141 patients with symptoms of HIV infection; a multicenter study]. Perenboom R; Reiss P; Danner SA; van 't Wout JW Ned Tijdschr Geneeskd; 1990 Jan; 134(3):120-4. PubMed ID: 2405287 [TBL] [Abstract][Full Text] [Related]
6. Report on a 3-year follow-up zidovudine (AZT) treatment in a group of HIV-positive patients with congenital clotting disorders. Sartori MT; Mares M; Zerbinati P; Stocco D; Girolami A Haematologia (Budap); 1994; 26(1):17-27. PubMed ID: 7959371 [TBL] [Abstract][Full Text] [Related]
7. Zidovudine and the natural history of the acquired immunodeficiency syndrome. Moore RD; Hidalgo J; Sugland BW; Chaisson RE N Engl J Med; 1991 May; 324(20):1412-6. PubMed ID: 2020297 [TBL] [Abstract][Full Text] [Related]
9. Improvement of the predictive value of CD4+ lymphocyte count by beta 2-microglobulin, immunoglobulin A and erythrocyte sedimentation rate. The Multicentre Cohort Study Group. Schwartländer B; Bek B; Skarabis H; Koch J; Burkowitz J; Koch MA AIDS; 1993 Jun; 7(6):813-21. PubMed ID: 8103341 [TBL] [Abstract][Full Text] [Related]
10. Outcomes of treatment with AZT of patients with AIDS and symptomatic HIV infection. Cox PH; Martin MA; Styer CM; Beall GN Nurse Pract; 1990 May; 15(5):36, 39-44. PubMed ID: 2342666 [TBL] [Abstract][Full Text] [Related]
11. [Zidovudine treatment and need of blood transfusion in patients with AIDS]. Ligtenberg PC; Hoepelman IM; Vrehen HM; Borleffs JC Ned Tijdschr Geneeskd; 1991 Jan; 135(4):130-3. PubMed ID: 2002856 [TBL] [Abstract][Full Text] [Related]
12. The efficacy and toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex (ARC): an open uncontrolled treatment study. Stambuk D; Youle M; Hawkins D; Farthing C; Shanson D; Farmer R; Lawrence A; Gazzard B Q J Med; 1989 Feb; 70(262):161-74. PubMed ID: 2512592 [TBL] [Abstract][Full Text] [Related]
13. Risk factors for Kaposi's sarcoma in patients with advanced human immunodeficiency virus disease treated with zidovudine. Zidovudine Epidemiology Study Group. Gallant JE; Moore RD; Richman DD; Keruly J; Chaisson RE Arch Intern Med; 1994 Mar; 154(5):566-72. PubMed ID: 8122950 [TBL] [Abstract][Full Text] [Related]
14. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results. Phair JP; Abels RI; McNeill MV; Sullivan DJ Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662 [TBL] [Abstract][Full Text] [Related]
15. Early versus deferred zidovudine monotherapy: impact on AIDS-free time and survival in the multicenter AIDS cohort study. Detels R; Muñoz A; Peng Y; Graham N; Mellors J; Phair J Antivir Ther; 1997 Jan; 2(1):21-9. PubMed ID: 11322263 [TBL] [Abstract][Full Text] [Related]
16. Zidovudine monotherapy versus zidovudine plus zalcitabine combination therapy in HIV-positive persons with CD4 cell counts 300-500 cells/mm3: a double-blind controlled trial. The M50003 Study Group Coordinating and Writing Committee. Moyle GJ; Bouza E; Antunes F; Smith D; Harris R; Warburg M; Walker M Antivir Ther; 1997 Dec; 2(4):229-36. PubMed ID: 11327442 [TBL] [Abstract][Full Text] [Related]
17. Modelling progression of CD4-lymphocyte count and its relationship to survival time. De Gruttola V; Tu XM Biometrics; 1994 Dec; 50(4):1003-14. PubMed ID: 7786983 [TBL] [Abstract][Full Text] [Related]
18. [Survival of patients with HIV-related tuberculosis. Study of mortality during the first 9 months of treatment]. Falqués Casanovas M; Langohr K; Gómez Melis G; García de Olalla Rizo P; Jansà López del Vallado JM; Caylà Buqueras JA Rev Esp Salud Publica; 1999; 73(5):549-62. PubMed ID: 10650746 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of zidovudine treatment in homosexual men with AIDS-related complex: factors influencing development of AIDS, survival and drug intolerance. Australian Zidovudine Study Group. Swanson CE; Tindall B; Cooper DA AIDS; 1994 May; 8(5):625-34. PubMed ID: 8060543 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]